As of 2025-06-03, the Intrinsic Value of Olema Pharmaceuticals Inc (OLMA) is -9.42 USD. This OLMA valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.37 USD, the upside of Olema Pharmaceuticals Inc is -315.30%.
Based on its market price of 4.37 USD and our intrinsic valuation, Olema Pharmaceuticals Inc (OLMA) is overvalued by 315.30%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.42 - -9.42 | -9.42 | -315.30% |
| P/E | (19.04) - (40.74) | (31.88) | -828.7% |
| DDM - Stable | (8.67) - (20.37) | (14.52) | -431.9% |
| DDM - Multi | (7.12) - (13.42) | (9.34) | -313.5% |
| Market Cap (mil) | 361.26 |
| Beta | 1.90 |
| Outstanding shares (mil) | 82.57 |
| Enterprise Value (mil) | 310.62 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.75% |
| Cost of Debt | 5.00% |
| WACC | 8.71% |